Le Lézard
Classified in: Ebola virus, Health, Science and technology
Subject: PDT

SystemOne Announces 4 New Countries Rolling Out GxAlert®



SPRINGFIELD, Mass. and JOHANNESBURG, South Africa, Sept. 28, 2017 /PRNewswire/ -- SystemOne, a connected diagnostics company developing data-driven healthcare insight and solutions, announces 4 new GxAlert® implementations in Africa and Eastern Europe.

SystemOne Support Specialist Victor Lubuku during a GxAlert implementation in the Philippines, with staff from ministry and funder organizations.

SystemOne develops networking and software solutions to rapidly move and utilize data from infectious disease diagnostics. SystemOne users receive over 40,000 instant alerts from diagnostic devices each month and benefit from a host of supervisory and quality-improving features, all designed to speed time to treatment for patients and improve program effectiveness for health ministries.

GxAlert, SystemOne's first connected diagnostics platform, is used in over 37 countries, primarily to move TB and MDR-TB results and information, but the platform is also used for other diseases, such as HIV and Ebola. The new GxAlert implementations include: Ukraine, Malawi, Mozambique and Ghana.

Each country is expected to connect between 50 and 130 diagnostic devices, with an estimated total of 308 new instruments to GxAlert within the next few months.

The addition of GxAlert in these high-burden-developing countries (HBDC) represents a commitment to moving diagnostic results quickly, getting patients onto treatment faster and working towards internally-supported goals to fight TB and MDR-TB.

"With the adoption of GxAlert globally, we are beginning to see dramatic system improvements in numerous countries which include improved inventory management, lower error and invalid rates, and advanced patient time to treatment," said Brad Cunningham, Vice President of Customer Solutions. "These four new countries are benefiting from the latest version of GxAlert, which we're improving all the time, even as we develop our new connectivity platform Aspect."

As SystemOne prepares to launch its newest platform, Aspect, all existing GxAlert customers, including those with in-country servers, can receive the latest updates, extra features, on-going training and improved layouts to the GxAlert platform at no additional cost.

About SystemOne:
SystemOne focuses on producing game-changing connectivity and data solutions to help speed detection and response to infectious disease. SystemOne's flagship product, GxAlert, is used in over 37 countries.

The company's new connectivity software, Aspect®, addresses additional infectious diseases, including Ebola, HIV, Malaria, Hepatitis C and more on a host of diagnostic devices.

SystemOne has offices in Springfield and Boston, MA, USA and Johannesburg, South Africa.

To contact SystemOne, email: info@systemone.id
Stay Updated @SystemOneCo on TwitterInstagram
Visit SystemOne online

 

SOURCE SystemOne


These press releases may also interest you

14 déc 2017
Merck & Co., Inc. , known as MSD outside Canada and the United States, announced today that the recently approved PREVYMIStm (letermovir) is expected to be available in Canada by the end of December 2017. The product is indicated for the prophylaxis...

14 déc 2017
Direct Relief grew into the seventh largest charity in the United States in 2017, according to Forbes Magazine's newly released annual ranking of the 100 largest U.S. charities. The medical aid group received $1.1 billion in donations in its 2017...

8 déc 2017
Her Excellency the Right Honourable Julie Payette, Governor General of Canada, will present the Meritorious Service Decorations (Civil Division) to 42 recipients from various sectors across the country on Tuesday, December 12, 2017, at 10:30 a.m.,...

8 déc 2017
Restated segment financials As announced in April 2017, Ericsson will start to report financials according to its new segments as of the fourth quarter 2017. To facilitate year-on-year comparisons, Ericsson today discloses the restated financials...

7 déc 2017
In the search for drugs that are effective against Ebola virus, scientists from SRI International and Collaborations Pharmaceuticals, Inc., led a study that used machine learning methods to identify tilorone dihydrochloride as a potential new...

7 déc 2017
Replikins Ltd. this week reported to the Healthcare Emergency Management Program of Boston University School of Medicine a four-fold increase in gene Replikin Counts in Global MERS-CoV from 2008 to 2017 (p<0.001) ? the highest ever recorded on...




News published on 28 september 2017 at 15:00 and distributed by: